Search clinical trials for: Dose decrease

Total 7779 results

Trevena Inc.

Completed

A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure (BLAST-AHF)

Acute Decompensated Heart Failure

United States, Bulgaria, Poland, Russian Federation, Germany, Romania, Argentina, Canada, Czechia, Hungary, Israel, Slovakia
Dr. Reddy's Laboratories Limited

Completed

Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults

Healthy

United States
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 691751 in Healthy Asian Male Volunteers

Healthy

Korea, Republic of
Bioverativ, a Sanofi company

Completed

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

Hemophilia A

United States, Japan
Sir Run Run Shaw Hospital

Recruiting

Molecular Basis of Loss Aversion

Healthy

China
Beijing Tiantan Hospital

Recruiting

RhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage

Intraventricular Hemorrhage

China
Akeso

Terminated

A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer

Ovarian Neoplasms | Ovarian Cancer | Recurrent Ovarian Carcinoma | Relapsed Ovarian Cancer

China
University of Vermont
International Centre for Diarrhoeal Disease Research, Bangladesh; Thrasher... and other collaborators

Completed

The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity

Rotavirus Infection | Vaccine Response Impaired | Vaccine Virus Shedding

Bangladesh
ThromboGenics

Completed

A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)

Diabetes Mellitus | Diabetic Retinopathy | Diabetic Macular Edema

United States
ThromboGenics

Completed

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Diabetes Mellitus | Diabetic Retinopathy | Diabetic Macular Edema

United States
Nestlé

Completed

Fiber Tolerability in Children Aged 3-7 Year (Fiber - TIC)

Signs and Symptoms, Digestive

France
LTN PHARMACEUTICALS, INC.

Completed

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer (ARMOR1)

Prostate Cancer

United States
Rob Erskine
University of East Anglia

Completed

Resistance Exercise and Hydrolyzed Collagen Supplementation

Diet, Food, and Nutrition

United Kingdom
Guangzhou Patronus Biotech Co., Ltd.

Recruiting

Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older

Herpes Zoster (HZ)

China
Otsuka Pharmaceutical Development & Commercialization...

Completed

Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers

Healthy

Australia
Shanghai Jiao Tong University Affiliated Sixth...

Not yet recruiting

Rapid Local Ischemic Postconditioning on Stroke After Thrombectomy (RAPIDIMPROVE)

Acute Ischemic Stroke
AstraZeneca
Clinact, Multihealth Group; Contract Research Organization

Recruiting

Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations (ROMEO)

Chronic Obstructive Pulmonary Disease | COPD

France
Canadian Cancer Trials Group

Active, not recruiting

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Prostate Carcinoma

Canada
Xuzhou Central Hospital

Completed

Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules

Lung Cancer | Lung; Node

China
Sun Pharma Advanced Research Company Limited

Completed

Study of SPARC1103 in Subjects With Spasticity

Spasticity

United States, Russian Federation, Ukraine
University Health Network, Toronto

Terminated

Ultralow Dose Thoracic Computed Tomography in Immunocompromised Patients (ULDCT-IC)

Leukemia

Canada
GlaxoSmithKline

Completed

Phase I Study of GW856553 (Losmapimod)

Acute Coronary Syndrome

Australia
University of Alabama at Birmingham
Pfizer

Completed

High Dose CVVHDF Compared to Standard Dose CVVHDF (CVVHDF)

Acute Renal Failure

United States
Seoul National University Bundang Hospital
GE Healthcare; National Research Foundation of Korea

Completed

Diagnosis of Acute Appendicitis: Low-dose Computed Tomography (CT) Versus Standard-dose CT

Appendicitis

Korea, Republic of
Baylor College of Medicine
University of Texas, Southwestern Medical Center at Dallas

Completed

Evaluating the Use of RFT5-dgA to Deplete Alloreactive Cells Prior to Haploidentical Stem Cell Transplantation

Leukemia | Cancer

United States
Virginia Commonwealth University
Gilead Sciences

Withdrawn

Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL (RIVe-CLL/SLL)

Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | Refractory Small Lymphocytic Lymphoma | SLL | Relapsed CLL | Relapsed Chronic Lymphocytic Leukemia | Relapsed Small Lymphocytic Lymphoma
Aerie Pharmaceuticals

Completed

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Diabetic Macular Edema | Neovascular Age-related Macular Degeneration

United States
Fu-Sheng Wang

Unknown

Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients

Human Immunodeficiency Virus | Disorder of Immune Reconstitution

China
Newish Technology (Beijing) Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting

NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection

Hepatocellular Carcinoma

China
Rznomics, Inc.

Active, not recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma

Hepatocellular Carcinoma

Korea, Republic of
Boehringer Ingelheim

Completed

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Psoriasis
Prague Psychiatric Center
Eli Lilly and Company

Completed

Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia

Schizophrenia

Czech Republic
DSciLab Co., Ltd.

Recruiting

A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)

Wilsons Disease

China
Titch Madzima

Completed

Assessing the Impact of High Theacrine Doses on Hemodynamic Measures

Cognitive Performance in Healthy Volunteers | Hemodynamic Measure

United States
Shire

Completed

Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

Metachromatic Leukodystrophy (MLD)

Denmark
Knopp Biosciences
Biogen

Completed

Dexpramipexole Japanese PK Study

Amyotrophic Lateral Sclerosis

United Kingdom
Allergan

Completed

AGN-199201 for the Treatment of Erythema With Rosacea

Erythema | Rosacea

United States
Pfizer

Completed

A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease

Respiratory Tract Diseases | Lung Diseases | Pulmonary Disease, Chronic Obstructive | COPD | Chronic Obstructive Airway Disease

Germany
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI); Transfusion Medicine/Hemostasis...

Completed

Optimal Platelet Dose Strategy for Management of Thrombocytopenia (PLADO)

Thrombocytopenia

United States
MediciNova

Completed

Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States
Hong Kong Baptist University

Completed

A Dose Determination Study of Chinese Herbal Medicine for Functional Constipation

Constipation

China
Medicines for Malaria Venture
Quotient Sciences; The Doctors Laboratory Ltd

Recruiting

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants

Malaria, Falciparum

United Kingdom
Seoul National University Hospital
Green Cross Corporation; LSK Global Pharma Services Co. Ltd.

Completed

Efficacy and Safety of Anthrax Vaccine, GC1109

Anthrax

Korea, Republic of
West China Second University Hospital

Completed

Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects

Healthy Volunteers

China
Huahui Health

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled HH-120 Aerosol in Healthy Volunteers

COVID-19 Respiratory Infection

Australia
Sun Pharma Advanced Research Company Limited

Completed

Safety Study of SPARC1104

Spasticity

United States
First Affiliated Hospital Xi'an Jiaotong University
Eureka Therapeutics Inc.

Unknown

Clinical Study of ET019002-T Cell Therapy for Refractory/Relapsed B-Cell Malignancies

B-Cell Malignancies
Cook Group Incorporated

Completed

Formula PTX Renal Stent Clinical Study

Renal Artery Stenosis

United Kingdom, Germany, Czechia, France
OcuNexus Therapeutics, Inc.

Completed

A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE) (DUNE)

Diabetic Foot Ulcers

Russian Federation, United States, Ukraine
Ikena Oncology
Gilead Sciences

Terminated

A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Breast Cancer | Head and Neck Cancer | Gynecologic Cancer | Colorectal Cancer | Pancreatic Cancer | Gastric Adenocarcinoma | Lung Adenocarcinoma | Advanced Solid Tumor

United States

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations